Corcept Therapeutics Inc (NASDAQ:CORT) traded at $101.86 at last check on current trade day and made an upward move of 86.46% on its previous day’s price.
Looking at the stock we see that its previous close was $54.63 and the beta (5Y monthly) reads 0.612 with the day’s price range being $87.5821 – $104.71. The company has a trailing 12-month PE ratio of 82.61. In terms of its 52-week price range, CORT has a high of $75.00 and a low of $20.84. The company’s stock has gained about 68.15% over that past 30 days.
Corcept Therapeutics Inc has a market cap of $10.75 billion and is expected to release its quarterly earnings report on 2025-Feb-25.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 177.94M, with a low of 175M and a high of 180M. The median projection represents growth squeezing down to 21.20% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 905.39M, or 34.12% up from figures reported last year.
On the other hand, looking at the outlook for the CORT stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy.
Based on estimates by 4 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Corcept Therapeutics Inc (CORT) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the CORT stock currently stands at 1.23, and the most recent price level today is 73.30% off its SMA20 and 63.07% from its 50-day simple moving average. The RSI (14) is pointing at 83.94 while the volatility over the past week is 3.89% and jumps to 4.90% over the past one month. The beta value is 0.65, while the average true range (ATR) is currently pointing at 6.19. The average price target for the stock over the next 12 months is $80, with the estimates having a low of $80 and a high of $80. These price ends are 21.46% and 21.46% off the today’s price level respectively, although investors could be excited at the prospect of a 21.46% if the CORT share price touches on the median price of $80.
Coming back to Corcept Therapeutics Inc (NASDAQ:CORT), we note that the average 3-month trading volume was 995.56K, while that of the preceding 10-day period stands at 0.86 million. Current shares outstanding are 105.11 million.
The insiders hold 11.68% of the company’s shares while institutions hold 80.21%. The data shows that short shares as of 2025-03-14, stood at 16.33 million at a short ratio of 12.6. This represents a 2167.00 short interest in shares outstanding on 2025-03-14. Shares short rose in March from the previous month at 15.39 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 102.15% up in year-to-date price movement.
